Pfizer Inc. Executive Compensation
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered in New York City.
Named Executive Officers — FY2024
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
Pfizer Inc.'s available SEC proxy filings disclose compensation for a single named executive officer: Albert Bourla (Chairman & CEO).
Cash compensation (salary plus bonus) made up 28% of Pfizer Inc.'s FY2024 tracked executive pay, with stock awards accounting for 69%. That's notably more stock-weighted than the typical Healthcare company in this dataset, where stock awards average 0% of tracked pay.
Among 78 other Healthcare companies in this dataset, Pfizer Inc.'s combined tracked executive pay of $20.3M ranks in the 69th percentile (industry median: $12.5M). Its highest-paid executive, Albert Bourla, ranks in the 86th percentile for top-executive pay in the sector (industry median: $6.0M).
Compensation figures on this page for Pfizer Inc. come directly from its SEC DEF 14A proxy statement(s), filed with the SEC via EDGAR — not from crowdsourced or self-reported salary data.